Big Movers: Nektar Therapeutics (NASDAQ:NKTR), Cleveland BioLabs, Inc ...

24-01-2014 SBWireComments (0)

BiotechnologyNektar Therapeutics

Nektar Therapeutics (NASDAQ: NKTR)'s shares increased 6.79% to $13.99. The company on Jan. 21 announced that it has commenced an underwritten public offering of 8,500,000 shares of its common stock. In connection with this offering, Nektar will also ...

Read more on SBWire

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top